Satoshi Akiba, Ryo Nagatomo, Tsuyoshi Ishimoto, Takashi Sato
{"title":"小檗胺对兔血小板胞浆磷脂酶A2活化的影响","authors":"Satoshi Akiba, Ryo Nagatomo, Tsuyoshi Ishimoto, Takashi Sato","doi":"10.1016/0922-4106(95)90075-6","DOIUrl":null,"url":null,"abstract":"<div><p>The effect of berbamine, a biscoclaurine alkaloid, on cytosolic phospholipase A<sub>2</sub> activation in rabbit platelets was investigated. Berbamine inhibited árachidonic acid liberation induced by thrombin but not that by ionomycin. The alkaloid did not affect thrombin-stimulated Ca<sup>2+</sup> mobilization, Ca<sup>2+</sup>-dependent translocation of cytosolic phospholipase A<sub>2</sub> to membranes, or the activity of partially purified cytosolic phospholipase A<sub>2</sub>. Furthermore, berbamine had no effect on the thrombin-elicited increase in cytosolic phospholipase A<sub>2</sub> activity. However, berbamine suppressed arachidonic acid liberation in platelets stimulated with GTP-binding protein activators. Although incubation of platelet membranes with a GTP analogue decreased the islet-activating protein-catalyzed ADP-ribosylation of an approximately 40 kDa protein in the membranes, pretreatment of the membranes with berbamine did not influence the decrease in ADP-ribosylation. These results suggest that berbamine may impair GTP-binding protein-mediated activation of cytosolic phospholipase A<sub>2</sub>, probably without influencing the enzyme translocation to membranes or the increase in the enzyme activity, and thus may cause the suppression of thrombin-induced arachidonic acid liberation.</p></div>","PeriodicalId":100502,"journal":{"name":"European Journal of Pharmacology: Molecular Pharmacology","volume":"291 3","pages":"Pages 343-350"},"PeriodicalIF":0.0000,"publicationDate":"1995-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0922-4106(95)90075-6","citationCount":"21","resultStr":"{\"title\":\"Effect of berbamine on cytosolic phospholipase A2 activation in rabbit platelets\",\"authors\":\"Satoshi Akiba, Ryo Nagatomo, Tsuyoshi Ishimoto, Takashi Sato\",\"doi\":\"10.1016/0922-4106(95)90075-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The effect of berbamine, a biscoclaurine alkaloid, on cytosolic phospholipase A<sub>2</sub> activation in rabbit platelets was investigated. Berbamine inhibited árachidonic acid liberation induced by thrombin but not that by ionomycin. The alkaloid did not affect thrombin-stimulated Ca<sup>2+</sup> mobilization, Ca<sup>2+</sup>-dependent translocation of cytosolic phospholipase A<sub>2</sub> to membranes, or the activity of partially purified cytosolic phospholipase A<sub>2</sub>. Furthermore, berbamine had no effect on the thrombin-elicited increase in cytosolic phospholipase A<sub>2</sub> activity. However, berbamine suppressed arachidonic acid liberation in platelets stimulated with GTP-binding protein activators. Although incubation of platelet membranes with a GTP analogue decreased the islet-activating protein-catalyzed ADP-ribosylation of an approximately 40 kDa protein in the membranes, pretreatment of the membranes with berbamine did not influence the decrease in ADP-ribosylation. These results suggest that berbamine may impair GTP-binding protein-mediated activation of cytosolic phospholipase A<sub>2</sub>, probably without influencing the enzyme translocation to membranes or the increase in the enzyme activity, and thus may cause the suppression of thrombin-induced arachidonic acid liberation.</p></div>\",\"PeriodicalId\":100502,\"journal\":{\"name\":\"European Journal of Pharmacology: Molecular Pharmacology\",\"volume\":\"291 3\",\"pages\":\"Pages 343-350\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0922-4106(95)90075-6\",\"citationCount\":\"21\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmacology: Molecular Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0922410695900756\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmacology: Molecular Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0922410695900756","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Effect of berbamine on cytosolic phospholipase A2 activation in rabbit platelets
The effect of berbamine, a biscoclaurine alkaloid, on cytosolic phospholipase A2 activation in rabbit platelets was investigated. Berbamine inhibited árachidonic acid liberation induced by thrombin but not that by ionomycin. The alkaloid did not affect thrombin-stimulated Ca2+ mobilization, Ca2+-dependent translocation of cytosolic phospholipase A2 to membranes, or the activity of partially purified cytosolic phospholipase A2. Furthermore, berbamine had no effect on the thrombin-elicited increase in cytosolic phospholipase A2 activity. However, berbamine suppressed arachidonic acid liberation in platelets stimulated with GTP-binding protein activators. Although incubation of platelet membranes with a GTP analogue decreased the islet-activating protein-catalyzed ADP-ribosylation of an approximately 40 kDa protein in the membranes, pretreatment of the membranes with berbamine did not influence the decrease in ADP-ribosylation. These results suggest that berbamine may impair GTP-binding protein-mediated activation of cytosolic phospholipase A2, probably without influencing the enzyme translocation to membranes or the increase in the enzyme activity, and thus may cause the suppression of thrombin-induced arachidonic acid liberation.